|

Apixaban Clinical Trials

14 actively recruiting trials across 8 locations

▲ +1 trial since July 2026

Also known as: 1-(4methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4c]pyridine-3-carboxamide, AVK, B01A F02, C25H25N5O4, Eliquis +3 more

Pipeline

Early 1: 1Phase 2: 2Phase 3: 3Phase 4: 6

Top Sponsors

  • Regeneron Pharmaceuticals2
  • Ottawa Hospital Research Institute2
  • Yale University1
  • VA Office of Research and Development1
  • University of Vermont Medical Center1

Indications

Other6 trials

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4
COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
Phase 4
Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
N/A
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
N/A
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Phase 4
Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
Phase 4

Birmingham, Alabama1 trial

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

University of Alabama Hospital

Phase 3

Dothan, Alabama1 trial

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

SEC Clinical Research

Phase 2

Tucson, Arizona1 trial

Apixaban Versus Warfarin for Left Ventricular Thrombus

Banner University Medical Center - Tucson

Phase 3

Hialeah, Florida1 trial

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Bioresearch Partner- Hialeah Hospital

Phase 3

Miami, Florida1 trial

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

Miami VA Healthcare System, Miami, FL

Phase 4

Boston, Massachusetts1 trial

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Early 1

Syracuse, New York1 trial

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

SUNY Upstate

Phase 4

Burlington, Vermont1 trial

Venous Thromboembolism Prevention in Outpatients With Glioma

University of Vermont Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.